biotech · Relapsed/Refractory Large B Cell Lymphoma · Relapsed/Refractory Multiple Myeloma · ALLO
Allogene Therapeutics
NovaPharmaNews editorial coverage mentioning Allogene Therapeutics — regulatory, clinical, and market analysis.
South San Francisco, USA HQ
2017 Founded
208 Employees
Public company Type
ALLO · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2017
- Employees
- 208
- Programs
- 8
- Drugs
- 2
- Patents
- 16
News & analysis
NovaPharmaNews articles mentioning Allogene Therapeutics — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Allogene Therapeutics — regulatory, clinical, and market analysis.
